News
Prof. Derya Unutmaz joins Floratek Pharma Scientific Advisory Board
Derya Unutmaz, M.D. from Marmara University, held postdoctoral positions at Novartis and NYU before … Read more
Prof. Francesco Bertoni joins Floratek Pharma Scientific Advisory Board
Francesco Bertoni graduated in Medicine and post-graduated in Medical Oncology at the State University … Read more
Discovery of first in class, polyphenolic inhibitors of CKAP4 and their antitumor activity in ovarian and endometrial cancer
At the upcoming AACR 2025 meeting in Chicago, USA, we will present a study … Read more
Recent studies revealed that Floratek’s new chemical entities exhibited picomolar activity in cancer cells
After meticulous SAR refinement through multiple rounds of chemical modifications the new generation of … Read more
Floratek Pharma is ranking 3rd in the most innovative Pharma SME in Switzerland
The recent innovation study was carried out by Swiss Institute for Quality Testing (SIQT), … Read more
Thrilled to announce new and very promising results
Floratek’s innovative approach to development of anti-cancer compounds has been rewarded with outstanding results … Read more